ArticleAnnals of medicine and surgery (2012)2025
Evaluating the role of PCSK9 inhibitors in reducing cardiovascular events among statin-intolerant patients: a systematic review and meta-analysis.
Muhammad Farhan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.